Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
The Development of Biomaterial Matrices For Xeno-Free Culture and Long-Term Maintenance of Human Pluripotent Stem Cells
EF 2015-16
Résumé
It is estimated that four out of five Canadians are at risk to develop degenerative chronic diseases, including diabetes and heart disease. Pluripotent stem cells (PSCs) show great promise as a potential future therapeutic for these degenerative diseases as stem cells have the ability to contribute to all tissues and organs in the human body, known as pluripotency. One substantial limiting factor in the translation of stem cell therapies from the lab to the clinic, however, is the absence of suitable growth conditions for PSCs. Current conditions used to derive and maintain PSCs contain animal products that present a significant risk of viral, bacterial, or parasitic transmission to stem cells. Moreover, these conditions may contain toxic biomolecules that may harm recipients of stem cell therapy. Therefore, there is a great need for a chemically defined culture system free of animal products that eliminates the risk of pathogen transmission to PSCs.
To this end, this study plans to address this need through i) developing a tool to rapidly test various synthetic, protein-coated biomaterials; ii) testing these biomaterials for their ability to maintain growth of PSCs; and iii) developing a model to predict which cells are optimal for stem cell therapy. The biophysical properties of the biomaterial and ten proteins known to be secreted by PSCs will be screened combinatorially to determine which condition best supports growth and pluripotency of PSCs.
The development of biomaterials from this study that are capable of maintaining growth and pluripotency of PSCs is critical to PSCs reaching their full therapeutic potential. These biomaterials will allow for the pathogen-free derivation and culture of PSCs, leading to the development of safe, clinical grade PSCs in a more cost-effective and reproducible manner. With the advent of patient-specific stem cells, biomaterials from our study will aid in establishing personalized stem cell therapies for degenerative diseases.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
339604
Name
Ireland Ronald
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
The Development of Biomaterial Matrices For Xeno-Free Culture and Long-Term Maintenance of Human Pluripotent Stem Cells
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Biomaterials; Biomedical Engineering; Cell Culture Technology; Extracellular Matrix; Human Pluripotent Stem Cells; Mechanobiology; Regenerative Medicine; Xenogenic-Free
Abstract
It is estimated that four out of five Canadians are at risk to develop degenerative chronic diseases, including diabetes and heart disease. Pluripotent stem cells (PSCs) show great promise as a potential future therapeutic for these degenerative diseases as stem cells have the ability to contribute to all tissues and organs in the human body, known as pluripotency. One substantial limiting factor in the translation of stem cell therapies from the lab to the clinic, however, is the absence of suitable growth conditions for PSCs. Current conditions used to derive and maintain PSCs contain animal products that present a significant risk of viral, bacterial, or parasitic transmission to stem cells. Moreover, these conditions may contain toxic biomolecules that may harm recipients of stem cell therapy. Therefore, there is a great need for a chemically defined culture system free of animal products that eliminates the risk of pathogen transmission to PSCs.
To this end, this study plans to address this need through i) developing a tool to rapidly test various synthetic, protein-coated biomaterials; ii) testing these biomaterials for their ability to maintain growth of PSCs; and iii) developing a model to predict which cells are optimal for stem cell therapy. The biophysical properties of the biomaterial and ten proteins known to be secreted by PSCs will be screened combinatorially to determine which condition best supports growth and pluripotency of PSCs.
The development of biomaterials from this study that are capable of maintaining growth and pluripotency of PSCs is critical to PSCs reaching their full therapeutic potential. These biomaterials will allow for the pathogen-free derivation and culture of PSCs, leading to the development of safe, clinical grade PSCs in a more cost-effective and reproducible manner. With the advent of patient-specific stem cells, biomaterials from our study will aid in establishing personalized stem cell therapies for degenerative diseases.
Competitiondate
201511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Ireland, Ronald
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~